Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community.
about
Cardiac target organ damage in hypertension: insights from epidemiologyCharacteristics of acute heart failure hospitalizations in a general medical ward in Southwestern UgandaUsing methods from the data-mining and machine-learning literature for disease classification and prediction: a case study examining classification of heart failure subtypes.Characterizing heart failure in the ventricular volume domainPatients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort studyPredicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure SubtypesCentral cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: implications for heart failure with preserved ejection fractionGender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failureHeart Failure in Women--Insights from the Framingham Heart Study.Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study.Management of pulmonary hypertension in left heart disease.Ventricular remodeling in heart failure with preserved ejection fraction.Biomarkers for risk prediction in acute decompensated heart failure.Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function.The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine.Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients.Presentation blood glucose and death, hospitalization, and future diabetes risk in patients with acute heart failure syndromes.Heart failure with preserved and reduced ejection fraction: different risk profiles for different diseases.The changing face of heart failure: are we really making progress?C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.Clinical findings and prognosis of patients hospitalized for acute decompensated heart failure: Analysis of the influence of Chagas etiology and ventricular function.Neurohormonal and clinical sex differences in heart failure.
P2860
Q27007701-872A9F52-5385-4486-AA04-BEA82FC3F487Q30371395-E705B3EE-E395-43CF-8F24-AFBA765F1FB6Q30587090-78FD9B65-DA5B-4A1E-969F-2C87BF29235BQ35135899-92C8C0D2-E3E7-41AC-BAFD-C67836741E25Q36199988-4D03EB1D-9C87-4710-8271-D5BF98EC5742Q36992652-68B1DC05-03A1-4673-87E7-50C4DFCE6B41Q37074089-15CBC645-A3DA-41EF-A426-2C5FF78074BDQ37078756-F055165F-3F55-45F6-A086-7BB94B0DD4FCQ37637447-F9713A88-B055-4723-8B68-AB7D34E53464Q37641033-E571A689-4170-4A19-A265-FC0458A23C0BQ38099630-DF74B1E7-CDED-4C75-A276-80D269BDC99DQ38149802-BB908B73-8A5A-4919-BDDB-5638EA59A7E7Q38222370-B4DCE57C-C51B-4C29-8B48-07B4A9266293Q38732534-F742F6DE-FDED-4ADF-ADBA-03D29253395BQ38755320-0F97C6A8-EA92-4573-9A38-F4C16F30994FQ38764956-9D987BEA-91A2-4FFE-AB49-2F39BC188343Q38893111-FEA2008D-3D34-4A30-A285-0FA732169242Q39062440-B9A00F6E-F882-4DDC-91D5-6A9842A4920CQ44233397-BF34CB37-E3DD-4BA6-9496-9A4E120A2038Q45819043-569343BC-637D-48D6-ADBE-389603227B54Q48787655-B3FB05FC-6534-484B-925D-DEDD5D1E2269Q50062333-DB3FBA89-2437-46D6-A779-31F8D652CBFBQ51000455-E6BD1CF8-FD92-4983-BE3C-5BC5A4538CC7
P2860
Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Discriminating clinical featur ...... ion fraction in the community.
@ast
Discriminating clinical featur ...... ion fraction in the community.
@en
type
label
Discriminating clinical featur ...... ion fraction in the community.
@ast
Discriminating clinical featur ...... ion fraction in the community.
@en
prefLabel
Discriminating clinical featur ...... ion fraction in the community.
@ast
Discriminating clinical featur ...... ion fraction in the community.
@en
P2093
P2860
P50
P356
P1476
Discriminating clinical featur ...... ion fraction in the community.
@en
P2093
Daniel Levy
Douglas S Lee
Ralph B D'Agostino
William B Kannel
P2860
P304
P356
10.1093/EURHEARTJ/EHS070
P577
2012-04-16T00:00:00Z